Prognosis
U.S. Covid-19 Cases Rise 2.4%, Deaths Top 75,000: Virus Update
This article is for subscribers only.
Moderna surged the most in more than two weeks after the company said its experimental vaccine would be in late-stage studies by early summer. Japan approved Gilead’s remdesivir to treat the novel coronavirus. U.S. cases rose 2.4%, matching the one-week average.
The White House is seeking revisions to a rejected Centers for Disease Control and Prevention plan to help local health authorities reopen businesses, according to reports. A U.S. agency withdrew approval for N-95 masks from China.